Search

everythinglearnresearchcommunity

for

Search:↓

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Men and premenopausal women in Korea show different patterns in iron and vitamin D levels, with no clear pattern for postmenopausal women.

Using rodents for research shows that health problems in the womb can cause diseases later in life.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

Plasma protein binding significantly affects glucocorticosteroid concentration in blood, saliva, and hair.

Gene mutations can cause problems in male genital development.

Male sexual differentiation is regulated independently, while female differentiation occurs in an androgenic environment, affecting conditions like congenital adrenal hyperplasia.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

Obesity affects skin health, causing conditions like acanthosis nigricans and may require different treatment approaches.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Androgens can both increase and decrease hair growth in different parts of the body.

The document concludes that accurate diagnosis of ichthyosis is crucial for treatment and genetic advice, and ongoing research is needed for better therapies.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

No true link between AGA and insulin resistance, but coexistence may worsen AGA.

Long-term fluticasone treatment does not harm the immune system in horses with heaves.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

With careful management, people with congenital adrenal hyperplasia can have successful pregnancies and become parents.

Women with PCOS have a higher risk of severe COVID-19 due to related health issues.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Obesity increases the risk of skin infections, inflammatory conditions, and melanoma, but not basal cell carcinoma.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Balding men have higher heart disease risk.

Some skin diseases and their treatments can negatively affect male fertility.

Spironolactone might cause painful intercourse and decreased sexual arousal in women.

Young women with nonclassic congenital adrenal hyperplasia may experience worse sexual function and mild depression compared to healthy women.